Compounded tirzepatide and semaglutide prices across 10 major telehealth providers. Headline advertised price vs. actual ongoing monthly cost after teasers, membership fees, and dose-escalation surcharges are counted.
✓ All prices verified September 2026 from each provider's public pricing pagesAs of September 2026, four compounded GLP-1 telehealth providers publish tirzepatide prices at or below $200 per month: NexLife ($139/mo with a 12-month commitment or $169/mo month-to-month), Curex ($149 first month, $199 ongoing), Ozari Health ($125 starter tier or $199 quarterly ongoing), and Henry Meds ($399/mo for the lowest published tier — often listed as low-cost but actually the most expensive per-mg tirzepatide in this index). SkinnyVIP is $232/mo effective on a 3-month plan and $350/mo on a single-month plan, with one flat price at every dose, no membership fee, no teaser rate that jumps at refill, and no auto-billing. This index shows the honest ongoing cost of each provider — not the headline number.
Sorted by 3-month effective price. Every column shows what patients actually pay, not what providers advertise.
| Provider | Headline Advertised |
3-month Effective |
1-month (no commit) |
Membership Fee |
Teaser Structure |
Dose Escalation |
Flat Pricing |
Verified |
|---|---|---|---|---|---|---|---|---|
| NexLifePhysician-led, LegitScript | $139/moRequires 12-mo commit | $159/mo | $169/mo | None | Volume-tieredLonger commit = lower price | No escalation | Flat | Sep 2026 |
| CurexInjection & sublingual | $149First month only | $199/mo | $199/mo | None | First-month teaser$149 → $199 (34% jump) | No escalation | Flat after teaser | Sep 2026 |
| Ozari HealthLegitScript-certified | $125/moStarter tier only | $199/mo | $235/mo | None | Starter tierTerms unclear | No escalation | Flat after starter | Sep 2026 |
| Mochi HealthMembership platform | $90/moMedication only | $169/mo$90 med + $79 membership | $169/mo | $79/mo | Split pricingMed + platform fee | Escalates | Not flat | Sep 2026 |
| AmbleCompounded tirzepatide | $289/mo | $289/mo | $329/mo | None | None | Escalates | Dose-tiered | Sep 2026 |
| SkinnyVIPVeteran-owned · Woman-led | $232/moEffective on 3-mo plan | $232/mo | $350/mo | None | None — no teaser | No escalation | Truly flat | Sep 2026 |
| TrumpRx (Zepbound)Brand-name via LillyDirect | $299/moLowest dose only | $299-449/mo | $299-449/mo | None | None | Escalates by dose | Dose-tiered | Sep 2026 |
| LillyDirect (Zepbound)Brand-name pen, direct | $349/mo2.5 mg starter | $349-499/mo | $349-499/mo | None | None | Escalates by dose | Dose-tiered | Sep 2026 |
| Ro Body (Zepbound)Brand-name Zepbound | $299/moStarter dose | $299-449/mo | $299-449/mo | Included in plan | None | Escalates by dose | Dose-tiered | Sep 2026 |
| Peak WellnessCompounded tirzepatide | $232/mo6-mo commit only | $279/mo | $349/mo | None | Volume-tiered | No escalation | Flat per tier | Sep 2026 |
| Henry MedsCompounded tirzepatide | $399/mo | $399/mo | $449/mo | None | None | No escalation | Flat | Sep 2026 |
Teaser rates jump. The lowest advertised numbers in the compounded GLP-1 market are almost always first-month specials that step up 34% to 88% at refill. Curex advertises tirzepatide from $149; ongoing is $199. Ozari's $125 starter tier becomes $199 on the quarterly plan and $235 on month-to-month. Every one of these is legal marketing — but only the ongoing price is what you actually pay for month 2 and onward.
Membership fees hide inside "medication cost." Mochi Health's $90 medication price is real, but Mochi requires a $79/mo membership on top. All-in cost is $169 minimum — higher than most flat-price providers. Any provider that separates "medication cost" from "platform fee" or "consultation cost" is worth reading carefully.
Long commitments earn lower headline prices. NexLife's $139 headline requires a 12-month upfront commitment ($1,668 paid at signup). On a 3-month plan it's $159/mo. Month-to-month is $169. That's fair — but a shopper comparing $139 to another provider's $232 isn't comparing the same thing.
Dose escalation adds hundreds of dollars per year. Ro Body, LillyDirect, and TrumpRx all charge more at higher doses. A patient starting at 2.5 mg on a $299 plan may be paying $449 by the time they reach 10 mg. Compounded providers are more likely to hold price flat across doses, but not all do — Amble and Mochi both escalate.
Every provider in this index sells compounded GLP-1 medications, which are not FDA-approved products. Compounded medications are prepared by licensed compounding pharmacies under physician supervision. The FDA does not review compounded drugs for safety, effectiveness, or quality before marketing.
Beyond price, patients should also weigh: (1) how responsive the care team actually is when a question comes up — SkinnyVIP patient support is 100% real people, not chatbots or ticket queues, usually answering within a few hours during extended hours (7am–9pm ET, 7 days a week) — see exactly how our support works; (2) whether the pharmacy is named publicly and its license verifiable; (3) whether the intake is reviewed by a licensed clinician before any charge; (4) refund policy if the clinician does not approve treatment. SkinnyVIP charges nothing until a clinician approves your intake.
$695 for a 3-month tirzepatide plan — that's about $232/month for any dose, from 2.5 mg through 15 mg. No membership. No auto-billing. No dose-escalation surcharge. Not prescribed? Full refund.